BioMedical Engineering and Imaging Institute

Medicine & Life Sciences

1. Atherosclerosis 100%
2. Magnetic Resonance Imaging 94%
3. Atherosclerotic Plaques 70%
4. Magnetic Resonance Spectroscopy 52%
5. Cardiovascular Diseases 41%
6. Thrombosis 40%
7. Myocardial Infarction 37%
8. Positron-Emission Tomography 34%
9. Therapeutics 34%
10. Coronary Artery Disease 32%
11. Contrast Media 31%
12. Inflammation 30%
13. Ketamine 30%
14. Blood Platelets 29%
15. Major Depressive Disorder 28%
16. Blood Vessels 28%
17. Nanoparticles 27%
18. Hepatocellular Carcinoma 27%
19. Acute Coronary Syndrome 27%
20. Macrophages 26%
21. Molecular Imaging 26%
22. Lipids 26%
23. Brain 25%
24. Liver 24%
25. Stroke 21%
26. Treatment-Resistant Depressive Disorder 21%
27. Swine 20%
28. Coronary Vessels 20%
29. Tomography 19%
30. White Matter 19%
31. Coronary Disease 19%
32. Fluorodeoxyglucose F18 19%
33. Multiparametric Magnetic Resonance Imaging 19%
34. Aspirin 18%
35. Rupture 18%
36. Perfusion 18%
37. Depression 17%
38. Biomarkers 17%
39. Rabbits 17%
40. Neoplasms 16%
41. Coronavirus 16%
42. Diffusion Magnetic Resonance Imaging 15%
43. Unstable Angina 15%
44. Aorta 15%
45. Antidepressive Agents 14%
46. Pulmonary Hypertension 14%
47. HDL Lipoproteins 14%
48. Percutaneous Coronary Intervention 14%
49. Elasticity Imaging Techniques 14%
50. Mortality 14%
51. Anisotropy 14%
52. Carotid Arteries 13%
53. Clinical Trials 13%
54. Placebos 13%
55. Hydroxymethylglutaryl-CoA Reductase Inhibitors 13%
56. Arteries 12%
57. Infarction 12%
58. Secondary Prevention 12%
59. Atrial Fibrillation 12%
60. Wounds and Injuries 12%
61. Post-Traumatic Stress Disorders 11%
62. Diffusion Tensor Imaging 11%
63. Heart Failure 11%
64. Positron Emission Tomography Computed Tomography 11%
65. Randomized Controlled Trials 11%
66. Health 11%
67. Schizophrenia 11%
68. Hypertension 11%
69. gadolinium ethoxybenzyl DTPA 11%
70. Coronary Artery Bypass 10%
71. Pathologic Constriction 10%
72. Confidence Intervals 10%
73. Area Under Curve 10%
74. Heart 10%
75. Artifacts 10%
76. Angioplasty 10%
77. Multiple Sclerosis 10%
78. Fibrosis 10%
79. Platelet Aggregation Inhibitors 10%
80. Gray Matter 10%
81. Connectome 10%
82. Arteritis 10%
83. Neuroimaging 9%
84. Reperfusion 9%
85. Warfarin 9%
86. Prostatic Neoplasms 9%
87. Metoprolol 9%
88. Health Promotion 9%
89. Prefrontal Cortex 9%
90. Pathology 9%
91. Pharmaceutical Preparations 9%
92. Gadolinium 9%
93. Technology 9%
94. Thoracic Aorta 9%
95. Cardiology 9%
96. Micelles 9%
97. Nanomedicine 9%
98. Thrombin 8%
99. Income 8%
100. Myocardium 8%